All News

The CDC reports that the epidemiologic evidence collected indicates that products reported to be kratom or contain kratom are a likely cause of the outbreak.

Restrictive eating, emotional eating, and binge eating are mental traps that keep us from reaching our goal.

A review of food allergies, ways pharmacists can provide education, and some great resources for information.

Does your pharmacy institution offer students the opportunity to earn a concentration alongside their PharmD degree?

A Pharmacy Benefit Manager (PBM) is a third party administrator contracted by health plans, employers, unions and government entities to manage prescription drug programs. A PBM acts as a fiscal intermediary between insurers/payors and pharmacies.

Federal judge finds that sofosbuvir (Sovaldi) and ledipasvir/sofosbuvir (Harvoni) do not infringe on Merck patents.

If passed, a bill that addresses the prevention and treatment of chronic diseases may ensure better care for patients.

Deep transcranial stimulation could provide more relief from fatigue among multiple sclerosis patients compared with other treatments.

Researchers discover underlying reason why patients with Huntington's disease have a significantly lower risk of cancer.

Investigational small molecule drug may be able to treat herpes and HIV.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Patients who achieved hepatitis C virus eradication experienced a reduction in hepatic steatosis and fibrosis.

Amantadine previously received FDA approval for antiviral and antiparkinsonian treatment.

A higher number of patients with ulcerative colitis treated with apremilast (Otezla) achieved clinical remission.

Many patients have food allergies, especially to nuts. These nut-free choices can help them enjoy safe alternatives without compromising on taste!

Vaccines prevent patients from acquiring serious and potentially fatal diseases. It is our job as pharmacists to utilize every opportunity we have to immunize patients.

Humans operate on a diurnal pattern and need sleep for brain development, physical and mental health, and cognitive function maintenance

Combining oncolytic viruses and immunotherapies may fight cancer more effectively.

Immunotherapy-related side effects can occur at any time and can affect any organ.

Treatment with durvalumab (Imfinzi) reduces the risk of disease progression among patients with non-small cell lung cancer.

The FDA recently approved durvalumab (Imfinzi) for the treatment of patients with stage 3 non-small cell lung cancer (NSCLC) whose tumors are unresectable and whose disease has not progressed following treatment with chemoradiation.

Enzalutamide (Xtandi) demonstrates a significant reduction in metastasis or death from castration-resistant prostate cancer

Top news of the day from across the health care landscape.

Making investments in vaccines could result in millions fewer deaths and cases of poverty.

PRDM14 is involved with embryonic development and may lead to germ cell tumors.

Top news of the day from across the health care landscape.

Many key specialty pharmacy issues discussed at the Payer/Managed Care Strategies for Specialty Medications Annual Symposium.

Health care professionals should provide resources that help patients with HIV practice self-care.

Top articles of the week from The American Journal of Pharmacy Benefits.